BDBM50258076 CHEMBL494843::N-(4-(N-benzyl-2-chlorophenylsulfonamido)-2-chlorophenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide

SMILES CC(O)(C(=O)Nc1ccc(cc1Cl)N(Cc1ccccc1)S(=O)(=O)c1ccccc1Cl)C(F)(F)F

InChI Key InChIKey=XUPXFYHPDJNHNA-UHFFFAOYSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50258076   

TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50258076(CHEMBL494843 | N-(4-(N-benzyl-2-chlorophenylsulfon...)
Affinity DataEC50: >3.00E+4nMAssay Description:Agonist activity at human LXRbeta expressed in human SH-SY5Y cells co-transfected with Gal4-LBD after 24 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOxysterols receptor LXR-alpha(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50258076(CHEMBL494843 | N-(4-(N-benzyl-2-chlorophenylsulfon...)
Affinity DataEC50: >3.00E+4nMAssay Description:Agonist activity at human LXRalpha expressed in human SH-SY5Y cells cotransfected with Gal4-LBD after 24 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOxysterols receptor LXR-alpha(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50258076(CHEMBL494843 | N-(4-(N-benzyl-2-chlorophenylsulfon...)
Affinity DataEC50: >1.00E+5nMAssay Description:Agonist activity at LXRalpha ligand binding domain by FRET based SRC1 recruitment assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Astrazeneca R&D SöDertäLje

Curated by ChEMBL
LigandPNGBDBM50258076(CHEMBL494843 | N-(4-(N-benzyl-2-chlorophenylsulfon...)
Affinity DataEC50:  880nMAssay Description:Agonist activity at LXRbeta ligand binding domain (unknown origin) by FRET based SRC1 recruitment assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed